Table 2.
Factors and covariates | β | 95% CI | P | |
---|---|---|---|---|
Lower | Upper | |||
Total anti-RBD Ig as dependent variablea | ||||
Severe disease | 0.670 | 0.279 | 1.060 | 0.001 |
Male sex | −0.238 | −0.428 | −0.047 | 0.015 |
Persistent symptoms | −0.351 | −0.574 | −0.129 | 0.002 |
Glucocorticoids | −0.217 | −0.601 | 0.167 | 0.267 |
Interferons | 0.258 | −0.022 | 0.538 | 0.071 |
Age | 0.012 | 0.004 | 0.020 | 0.003 |
Length of stay | 0.030 | 0.011 | 0.049 | 0.002 |
Time from discharge | 0.030 | 0.012 | 0.047 | 0.001 |
Anti-RBD IgG as dependent variablea | ||||
Severe disease | 0.442 | 0.150 | 0.735 | 0.003 |
Male sex | −0.151 | −0.293 | −0.008 | 0.038 |
Persistent symptoms | −0.211 | −0.378 | −0.045 | 0.013 |
Glucocorticoids | −0.079 | −0.366 | 0.209 | 0.591 |
Interferons | 0.047 | −0.163 | 0.256 | 0.662 |
Age | 0.010 | 0.004 | 0.016 | 0.001 |
Length of stay | 0.012 | −0.002 | 0.026 | 0.101 |
Time from discharge | 0.010 | −0.003 | 0.024 | 0.120 |
Anti-N IgG as dependent variablea | ||||
Severe disease | 0.399 | 0.093 | 0.705 | 0.011 |
Male sex | 0.006 | −0.143 | 0.156 | 0.936 |
Persistent symptoms | −0.164 | −0.338 | 0.010 | 0.065 |
Glucocorticoids | −0.133 | −0.433 | 0.168 | 0.388 |
Interferons | 0.032 | −0.188 | 0.251 | 0.778 |
Age | 0.010 | 0.003 | 0.016 | 0.003 |
Length of stay | 0.001 | −0.014 | 0.016 | 0.925 |
Time from discharge | 0.002 | −0.011 | 0.016 | 0.725 |
aAll antibody concentrations were log10-transformed